Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global Hemp Group Inc C.GHG

Alternate Symbol(s):  GBHPF

Global Hemp Group Inc. is a Canada-based company. The Company is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. It is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). It acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.


CSE:GHG - Post by User

Bullboard Posts
Comment by Leavemealoneon Aug 14, 2017 4:57pm
122 Views
Post# 26580229

RE:Louiseville Usine De Pot Construction

RE:Louiseville Usine De Pot Construction
MARTIN LAFRENIRE
The New Yorker
(Louiseville) The project to set up a therapeutic marijuana plant in Louiseville is taking another step. The developers will soon begin construction of a 60,000-square-foot plant in the regional park of the Maskinong MRC, a project valued at $ 4.4 million.
 
In May 2016, the Maskinong RCM sold approximately 700,000 square feet of land to these developers from outside the region.
 
However, they are awaiting Health Canada's decision to apply for a license to produce pot for medical purposes.
 
The construction of the mill is part of the process put in place by the Canadian government.
 
If the project is accepted by Health Canada, the plant should hire about 15 workers in the short term.

Bullboard Posts